TAO WU to Carcinoma, Hepatocellular
This is a "connection" page, showing publications TAO WU has written about Carcinoma, Hepatocellular.
Connection Strength
0.188
-
Cell Cycle-Related LncRNA-Based Prognostic Model for Hepatocellular Carcinoma: Integrating Immune Microenvironment and Treatment Response. Curr Med Sci. 2024 Dec; 44(6):1217-1231.
Score: 0.122
-
Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis. Hepatology. 2016 Mar; 63(3):898-913.
Score: 0.066